Structures by: Loughzail M.
Total: 7
1-(Cyclohex-1-en-1-yl)-3-[(1-phenyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl]-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one
C22H21N5O
IUCrData (2017) 2, 6 x170907
a=8.5878(8)Å b=9.0603(8)Å c=12.8566(12)Å
α=85.076(7)° β=82.558(7)° γ=70.917(8)°
(<i>E</i>)-2-Phenyl-4-styryl-2,3-dihydro-1<i>H</i>-1,5-benzodiazepine hemihydrate
C23H20N2,0.5(H2O1)
IUCrData (2017) 2, 7 x171070
a=22.1001(8)Å b=6.7624(2)Å c=24.5714(7)Å
α=90° β=104.835(3)° γ=90°
Ethyl 2-(1<i>H</i>-benzimidazol-2-yl)-2-[2-(4-nitrophenyl)hydrazinylidene]acetate
C17H15N5O4
Acta Crystallographica Section E (2015) 71, 4 o236-o237
a=12.877(5)Å b=5.874(5)Å c=21.988(5)Å
α=90.000(5)° β=99.060(5)° γ=90.000(5)°
<i>N</i>-[4-Acetyl-5-isobutyl-5-(2-p-tolylpropyl)-4,5-dihydro-1,3,4-thiadiazol- 2-yl]acetamide ethyl acetate hemisolvate
C20H29N3O2S,0.5(C4H8O2)
Acta Crystallographica Section E (2009) 65, 1 o4
a=7.8713(3)Å b=12.7587(5)Å c=22.9688(9)Å
α=90.00° β=90.937(2)° γ=90.00°
4-Phenyl-1-(prop-2-yn-1-yl)-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C18H14N2O
Acta Crystallographica Section E (2011) 67, 8 o2075-o2076
a=8.2574(14)Å b=18.961(3)Å c=9.0914(15)Å
α=90.00° β=102.962(4)° γ=90.00°
(<i>E</i>)-3-[(Dimethylamino)methylidene]-4-phenyl-1-(prop-2-ynyl)-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C21H19N3O
Acta Crystallographica Section E (2014) 70, 1 o32
a=12.8122(10)Å b=13.9317(12)Å c=19.7795(14)Å
α=90.00° β=94.647(3)° γ=90.00°
(<i>E</i>)-3-[(Dimethylamino)methylidene]-4-phenyl-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C18H17N3O
Acta Crystallographica Section E (2014) 70, 2 o126
a=11.281(2)Å b=14.005(4)Å c=20.124(3)Å
α=90.00° β=95.970(10)° γ=90.00°